Phase I is purely post-synaptic with constant twitch depression, whereas Phase II reflects combined mechanisms with characteristic fade on repetitive stimulation
flexible ratios Cycle driver Whichever compound titrates more slowly Cagrilintide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Semaglutide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Weekly Schedule Example (Maintenance) Same day each week Cagrilintide 2.4 mg SubQ + Semaglutide 2.4 mg SubQ Use separate syringes for each compound
The most commonly reported side effect was mild headache, occurring at rates comparable to placebo
Advances in nutrition (Bethesda, Md.) , 11 (3), 576601
Avoid use during pregnancy or breastfeeding unless prescribed
Its disintegration products are immune-modulating, ecologically benign, and are unlikely to build up inside the circulatory system